BDBM291359 (E)-3-[2-(1H-Indol-4-yl)-4-morpholin-4-yl-pyrido[3′,2′:4,5]furo[3,2-d]pyrimidin-8-yl]-N,N-dimethylacrylamide::US9580442, Example G::US9938290, G
SMILES CN(C)C(=O)\C=C\c1cnc2oc3c(nc(nc3c2c1)-c1cccc2[nH]ccc12)N1CCOCC1
InChI Key InChIKey=MMCLGQOGMBMOJC-VOTSOKGWSA-N
Data 8 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 8 hits for monomerid = 291359
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
Affinity DataIC50: 223nMAssay Description:PI3K Isoform using biochemical assay.More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
Affinity DataIC50: 83nMAssay Description:PI3K Isoform using biochemical assay.More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
Affinity DataIC50: 5nMAssay Description:PI3K Isoform using biochemical assay.More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
Affinity DataIC50: 1.66E+3nMAssay Description:Please see articleMore data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
Affinity DataIC50: 1.66E+3nMAssay Description:PI3K Isoform using biochemical assay.More data for this Ligand-Target Pair